Imatinib radiosensitizes bladder cancer by targeting homologous recombination.

@article{Qiao2013ImatinibRB,
  title={Imatinib radiosensitizes bladder cancer by targeting homologous recombination.},
  author={Boling Qiao and Martin Kerr and Blaz Groselj and Mark T W Teo and Margaret A Knowles and Robert G. Bristow and Roger M. Phillips and Anne E Kiltie},
  journal={Cancer research},
  year={2013},
  volume={73 5},
  pages={1611-20}
}
Radiotherapy is a major treatment modality used to treat muscle-invasive bladder cancer, with patient outcomes similar to surgery. However, radioresistance is a significant factor in treatment failure. Cell-free extracts of muscle-invasive bladder tumors are defective in nonhomologous end-joining (NHEJ), and this phenotype may be used clinically by combining radiotherapy with a radiosensitizing drug that targets homologous recombination, thereby sparing normal tissues with intact NHEJ. The… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
15 Extracted Citations
36 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 15 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 36 references

Similar Papers

Loading similar papers…